Skip to main content
25 January 2021
Last updated:
Monday 25 January 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
    • News
    • Appointments
    • Events
  • About MedNous
  • Research Directory
  • Contact Us

News - Appointments

T-knife appoints Thomas Soloway as chief executive

Thursday 21 January 2021
Company
T-knife GmbH
Appointee Name
Thomas Soloway and  
Camille Landis

T-knife GmbH, which is developing adoptive T cell therapies, has appointed Thomas Soloway as chief executive, and Camille Landis as chief business officer and chief financial officer, ahead of its transition from a discovery to a clinical-stage company.

Country

Germany

  • Read more about T-knife appoints Thomas Soloway as chief executive

Domainex makes two executive appointments

Thursday 21 January 2021
Company
Domainex Ltd
Appointee Name
Ray Boffey and 
David Cronk

UK-based Domainex Ltd has made two appointments to its executive team as it expands its service business to the global biopharmaceutical industry.

Country

United Kingdom

  • Read more about Domainex makes two executive appointments

Richard Francis named CEO of Purespring

Tuesday 19 January 2021
Company
Purespring Therapeutics Ltd
Appointee Name
Richard 
Francis

Richard Francis, former chief executive of the Sandoz division of Novartis, has been named CEO of the gene therapy company Purespring Therapeutics Ltd, effective 1 February. Purespring was launched in November 2020 to develop AAV gene therapies for kidney disease.

Country

United Kingdom

  • Read more about Richard Francis named CEO of Purespring

Klaas Zuideveld becomes CEO of Versameb

Saturday 16 January 2021
Company
Versameb AG
Appointee Name
Klaas 
Zuideveld

Klaas Zuideveld has been appointed chief executive of Versameb AG, a Swiss company developing RNA-based therapeutics. He was previously chief development officer. At the same time, Friedrich Metzger, the company’s co-founder and former CEO, has become chief scientific officer.

Country

Switzerland

  • Read more about Klaas Zuideveld becomes CEO of Versameb

MorphoSys appoints new CFO

Thursday 7 January 2021
Company
MorphoSys AG
Appointee Name
Sung 
Lee

MorphoSys AG has appointed Sung Lee as chief financial officer effective 2 February as it commercialises its first oncology product on the US market. Mr Lee joins from Sangamo Therapeutics Inc where he was CFO.

Country

Germany

  • Read more about MorphoSys appoints new CFO

Sam Herbert becomes COO at Clinigen

Wednesday 6 January 2021
Company
Clinigen Group Plc
Appointee Name
Sam 
Herbert

Clinigen Group Plc has appointed Sam Herbert as chief operating officer to help build the company’s pharmaceutical services business. He was previously president of World Courier, a medical logistics company.

Country

United Kingdom

  • Read more about Sam Herbert becomes COO at Clinigen

Wolfgang Baiker becomes CEO at Adrenomed

Wednesday 6 January 2021
Company
Adrenomed AG
Appointee Name
Wolfgang 
Baiker

Wolfgang Baiker, a venture partner with Wellington Partners, has been appointed chief executive of Adrenomed AG which is developing a product for septic shock.

Country

Germany

  • Read more about Wolfgang Baiker becomes CEO at Adrenomed

Alligator Bioscience appoints new CMO

Tuesday 29 December 2020
Company
Alligator Bioscience AB
Appointee Name
Christina 
Reimer

Sweden-based Alligator Bioscience AB has appointed Christina Reimer as chief medical officer, effective 1 February 2021, as it progresses three new cancer therapies in the clinic. She joins from Ferring Pharmaceuticals in Copenhagen where she was senior medical director.

Country

Sweden

  • Read more about Alligator Bioscience appoints new CMO

Allero Therapeutics expands management team

Wednesday 16 December 2020
Company
Allero Therapeutics BV
Appointee Name
Steven Glazer and 
Christophe Saillez

The Belgian-Dutch company Allero Therapeutics BV has appointed Steven Glazer as chief medical officer and Christophe Saillez as vice president for regulatory affairs.

Country

Belgium

  • Read more about Allero Therapeutics expands management team

Jane Dancer becomes director at NanoSyrinx

Saturday 12 December 2020
Company
NanoSyrinx Ltd
Appointee Name
Jane 
Dancer

The UK start-up NanoSyrinx Ltd has appointed Jane Dancer to its board as a non-executive director as the company launches its platform for delivering therapeutic proteins to the cytosol.

Country

United Kingdom

  • Read more about Jane Dancer becomes director at NanoSyrinx

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page next ›
  • Last page last »

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

T-knife appoints Thomas Soloway as chief executive
Thursday January 21 2021
Domainex makes two executive appointments
Thursday January 21 2021
Richard Francis named CEO of Purespring
Tuesday January 19 2021
Klaas Zuideveld becomes CEO of Versameb
Saturday January 16 2021
MorphoSys appoints new CFO
Thursday January 7 2021

© 2021 Evernow Publishing Ltd. Powered by Drupal.